On 2024-11-14, Biora Therapeutics, Inc. (BIORQ) announced earnings per share of $-6.08 for the fiscal quarter ending 2024-09-30, missing the average analyst estimate of $-3.85.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-11-14 | 2024-09-30 | $-3.85 | $-6.08 |
| 2024-08-12 | 2024-06-30 | $-4.50 | $-3.50 |
| 2024-05-15 | 2024-03-31 | $-4.50 | $-6.10 |
| 2024-03-26 | 2023-12-31 | $-6.00 | $-6.30 |
| 2023-11-13 | 2023-09-30 | $-9.30 | $-7.50 |
| 2023-08-14 | 2023-06-30 | $-16.00 | $-14.70 |
| 2023-05-15 | 2023-03-31 | -- | $-15.90 |
| 2023-03-30 | 2022-12-31 | $-8.90 | $-16.10 |
| 2022-11-14 | 2022-09-30 | $-15.00 | $-20.00 |
| 2022-08-15 | 2022-06-30 | $-32.50 | $-7.50 |
| 2022-05-10 | 2022-03-31 | $-30.00 | $-30.00 |
| 2022-03-28 | 2021-12-31 | $-32.50 | $-52.50 |
| 2021-11-10 | 2021-09-30 | $-117.50 | $-95.00 |
| 2021-08-12 | 2021-06-30 | $-200.00 | $-162.50 |
| 2021-05-13 | 2021-03-31 | $-207.50 | $-140.00 |
| 2021-03-18 | 2020-12-31 | $-190.00 | $-382.50 |
| 2020-11-09 | 2020-09-30 | $-155.00 | $-252.50 |
| 2020-08-13 | 2020-06-30 | $-190.00 | $-1527.50 |